Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(4-((2-chloro-4,4-difluorospiro(5h-thieno(2,3-c)pyran-7,4'-piperidine)-1'-yl)methyl)-3-methylpyrazol-1-yl)-3-pyridyl)methanol
2. Ly2940094
1. 1307245-86-8
2. Ly-2940094
3. Ly2940094
4. Btrx-246040
5. Ly 2940094 - Bio-x
6. (2-(4-((2'-chloro-4',4'-difluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)methyl)-3-methyl-1h-pyrazol-1-yl)pyridin-3-yl)methanol
7. 4i67us2v8q
8. J3.309.394b
9. 1307245-86-8 (free Base)
10. [2-[4-[(2-chloro-4,4-difluorospiro[5h-thieno[2,3-c]pyran-7,4'-piperidine]-1'-yl)methyl]-3-methylpyrazol-1-yl]pyridin-3-yl]methanol
11. 2-(3-methyl-4-((2-chloro-4,4-difluorospiro(5h-thieno(2,3-c)pyran-7,4'-piperidine)-1'-yl)methyl)-1h-pyrazole-1-yl)pyridine-3-methanol
12. [2-[4-[(2-chloro-4,4-difluoro-spiro[5h-thieno[2,3-c]pyran-7,4'-piperidine]-1'-yl)methyl]-3-methyl-pyrazol-1-yl]-3-pyridyl]methanol
13. 2-[3-methyl-4-[(2-chloro-4,4-difluorospiro[5h-thieno[2,3-c]pyran-7,4'-piperidine]-1'-yl)methyl]-1h-pyrazole-1-yl]pyridine-3-methanol
14. Unii-4i67us2v8q
15. Gtpl9462
16. Schembl1807310
17. Schembl1809717
18. Chembl3304244
19. Dtxsid201336137
20. Bcp30786
21. Ex-a3004
22. Sb19609
23. Compound 36 [pmid: 24678969]
24. Ac-36290
25. Hy-114452
26. Cs-0085528
27. E74551
28. Ly 2940094; Ly2940094
29. [2-[4-[(2-chloro-4,4-difluoro-spiro[5hthieno[2,3-c]pyran-7,4'-piperidine]-1'-yl)methyl]-3-methyl-pyrazol-1-yl]-3-pyridyl]methanol
| Molecular Weight | 481.0 g/mol |
|---|---|
| Molecular Formula | C22H23ClF2N4O2S |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 480.1198312 g/mol |
| Monoisotopic Mass | 480.1198312 g/mol |
| Topological Polar Surface Area | 91.6 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 672 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
89
PharmaCompass offers a list of LY-2940094 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right LY-2940094 manufacturer or LY-2940094 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred LY-2940094 manufacturer or LY-2940094 supplier.
PharmaCompass also assists you with knowing the LY-2940094 API Price utilized in the formulation of products. LY-2940094 API Price is not always fixed or binding as the LY-2940094 Price is obtained through a variety of data sources. The LY-2940094 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LY-2940094 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LY-2940094, including repackagers and relabelers. The FDA regulates LY-2940094 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LY-2940094 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LY-2940094 supplier is an individual or a company that provides LY-2940094 active pharmaceutical ingredient (API) or LY-2940094 finished formulations upon request. The LY-2940094 suppliers may include LY-2940094 API manufacturers, exporters, distributors and traders.
LY-2940094 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LY-2940094 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LY-2940094 GMP manufacturer or LY-2940094 GMP API supplier for your needs.
A LY-2940094 CoA (Certificate of Analysis) is a formal document that attests to LY-2940094's compliance with LY-2940094 specifications and serves as a tool for batch-level quality control.
LY-2940094 CoA mostly includes findings from lab analyses of a specific batch. For each LY-2940094 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LY-2940094 may be tested according to a variety of international standards, such as European Pharmacopoeia (LY-2940094 EP), LY-2940094 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LY-2940094 USP).
